Superdisintegrants used in pharmaceutical technology
Authors:
Jan Gajdziok
Published in the journal:
Čes. slov. Farm., 2018; 67, 59-65
Category:
Review Articles
Summary
Disintegrants are substances which promote disintegration of the solid dosage form in the dissolution medium or body fluids. Efficient disintegration is an important prerequisite for ensuring release of the active substance and its good bioavailability. Several mechanisms of disintegrants´ action are currently recognized, but disintegration is a complex process, and the majority of substances act by combining multiple mechanisms. Superdisintegrants as an innovative materials allow more efficient disintegration of the dosage form in lower concentrations, without any negative impact on processability and mechanical properties of the final dosage form. Currently are in pharmaceutical technology used synthetic, modified (semi-synthetic), and also natural superdisintegrants, whose main representatives discribes this article.
Key words:
disintegrants • superdisintegrants • solid dosage forms • tablets • disintegration time • excipients
Zdroje
1. Bhowmik D., Chiranjib B., Yadav J., Chandira R. M., Kumar S. Emerging trends of disintegrants used in formulation of solid dosage form. Pharm. Lett. 2010; 2, 495–504.
2. Mangal M., Thakral S., Goswami M., Ghai P. Superdisintegrants: An updated review. Int. J. Pharm. Pharm. Sci. 2012; 2, 26–35.
3. Roy D., Bhowmik D., Kumar K. S. A comprehensive review on superdisintegrants used in orodispersible tablets. Indian J. Res. Pharm. Biotechnol. 2014; 2, 1297–1303.
4. Mohanachandran P. S., Sindhumol P. G., Kiran T. S. Superdisintegrants: An overview. Int. J. Pharm. Sci. Rev. Res. 2011; 6, 105–109.
5. Priyanka S., Vandana S. A review article on: Superdisintegrants. Int. J. Drug Res. Technol. 2017; 3, 11.
6. Guyot-Hermann A. M., Ringard D. J. Disintegration mechanisms of tablets containing starches. Hypothesis about the particle-particle repulsive force. Drug Dev. Ind. Pharm. 1981; 7, 155–177.
7. Naga A. T., Sambasiva R. A. Traditional and emerging disintegrants: A review. Int. J. Pharm. Sci. Rev. Res. 2013; 22, 205–212.
8. Moreton R. CH. Disintegrants in tableting. In: Augsburger L. L., Hoag S. W. (eds.) Pharmaceutical dosage forms – Tablets, 3rd ed. New York: Informa Healthcare 2008.
9. Nagar P. K., Parvez N., Sharma P. K. Superdisintegrants – current approach. J. Drug Deliv. Therapeutics. 2014; 4, 37–44.
10. FE Pharma. Superdisintegrants: Technical papers: Introduction to chemistry and performance. http://www.dfepharma.com/en/excipients/superdisintegrants/technical-documents.aspx (5. 3. 2016).
11. Medicines complete. Excipient: sodium starch glycolate (Glycolys). https://www.medicinescomplete.com/mc/excipients/current/login.htm?uri=https%3A%2F%2Fwww.medicinescomplete.com%2Fmc%2Fexcipients%2F2012%2F1002062746.html (25. 4. 2016).
12. Rowe R. C., Sheskey P. J., Owen S. C. Handbook of pharma-ceutical excipients. 6th ed. Washington DC: American Pharmacists Association 2009.
13. Ministerstvo zdravotnictví ČR. Český lékopis 2009. Praha: Grada Publishing 2009.
14. Zhao N., Augsburger L. L. The influence of swelling capacity of superdisintegrants in different pH media in the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS PharmSciTech. 2005; 6, E120–E126.
15. Medicines complete. Excipient: croscarmellose sodium (Ac-Di-Sol). https://www.medicinescomplete.com/mc/excipients/current/login.htm?uri=https%3A%2F%2Fwww.medicinescomplete.com%2Fmc%2Fexcipients%2F2012%2F1002154757.html (25. 4. 2016).
16. Bindra D. S., Stein D., Pandey, P., Barbour N. Incompatibility of croscarmellose sodium with alkaline excipients in a tablet formulation. Pharm. Dev. Technol. 2014; 19, 285–289.
17. Larsen J., Melander C. Study of interaction between croscar-mellose and escitalopram during sample preparation. Drug Dev. Ind. Pharm. 2012; 38, 1195–1199.
18. Bühler V. Polyvinylpyrrolidone Excipients for Pharmaceuticals, 1st ed. Berlin: Springer 2005.
19. Prokopová I. Makromolekulární chemie. 2. vydání. Praha: VŠCHT 2007.
20. Basf S. E. Products & Industries: Kollidon® CL-F. https://industries.BASF SE.com/en/Drug–Formulation/Kollidon–CL-F.html (1. 11. 2017).
21. Shin-Etsu Chemical. Low-Substituted Hydroxypropyl Cellulose NF. http://www.elementoorganika.ru/files/lhpc.pdf (12. 4. 2017).
22. Colorcon. Product brochure: Starch 1500. https://www.colorcon.com/literature/marketing/ex/Starch%201500/COLORCON_Starch_1500_Brochure_2008.01.15_Webiste.pdf (14. 8. 2017).
23. Kaur A. L. P. Superdisintegrants: An arising exemplar in orodispersible tablets. Int. J. Drug Res. Technol. 2015; 5.
24. Bele M. H., Derle D. V. Effect of polacrilin potassium as disintegrant on bioavailability of diclofenac potassium in tablets: A technical note. AAPS PharmSci Tech. 2012; 13, 756–759.
25. Yadav N. D., Pingale P. L., Tatane, S. R. Comparative study on effect of natural and artificial superdisintegrant in the formulation of fast dissolving aspirin tablet. J. Pharm. Res. 2010; 3, 1594–1597.
26. Hřivna L. Technologie sacharidů. Brno: Mendelova univerzita v Brně 2014.
27. Biotox. Slizy a kleje. http://www.biotox.cz/naturstoff/chemie/ch–sach–slizy.html (16. 5. 2016).
28. Pawan P., Sudhir CH., Mayur P. Natural superdisintegrants: Recent investigations and current approaches. Int. J. Pharm. Sci. 2012; 3, 2015–2026.
29. Mehta D. M., Shelat P. K., Parejiya P. B., Patel A. J., Barot, B. Investigations of Plantago ovata husk powder as a disintegrating agent for development of famotidine tablets. Int. J. Pharm. Sci. Nanotechnol. 2011; 4, 1412–1417.
30. Shirsand S. B., Suresh S., Para M. S., Swamy P. V., Kumar, D. N. Plantago ovata mucilage in the design of fast disintegrating tablets. Indian J. Pharm. Sci. 2009; 71, 41.
31. Kumar M. U., Babu M. K. Design and evaluation of fast dissolving tablets containing diclofenac sodium using fenugreek gum as a natural superdisintegrant. Asian Pac. J. Trop. Biomed. 2014; 4, S329–S334.
32. Shah V., Patel R. Studies on mucilage from Hibiscus Rosa-Sinensis Linn as oral disintegrant. Int. J. App. Pharm. 2010; 2, 18–21.
33. Velíšek J. Chemie potravin. 1. vyd. Tábor: OSSIS 1999. 339 s.
34. Shrivastava M., Kapoor V. P. Seed galactomannana: An overview. Chem. Biodivers. 2005; 2, 295–317.
35. Sharma B. R., Kumar V., Soni, P. L. Carbamoylethylation of Cassia tora gum. Carbohydr. Polym. 2003; 54, 143–147.
36. Soni P. L., Sharma P. Cassia tora gum as viscosifier and fluid loss control agent in oil well drilling. India Patent Application No. 680/DEL/2000. 25. 7. 2000.
37. Osmałek T., Froelich A., Tasarek S. Application of gellan gum in pharmacy and medicine. Int. J. Pharm. 2014; 466, 328–340.
38. Gohel M. C., Parikh R. K., Brahmbhatt B. K., Shah A. R. Preparation and assessment of novel coprocessed superdisintegrant consisting of crospovidone and sodium starch glycolate: a technical note. AAPS PharmSciTech. 2007; 8, E63–E69.
39. Vraníková B., Pavloková S., Gajdziok, J. Experimental design for determination of effects of superdisintegrant combinations on liquisolid system properties. J. Pharm. Sci. 2017; 106, 817–825.
40. Mirani G. A., Patankar P. S., Borole S. V., Pawar S. A., Kadam J. V. Direct compression high functionality excipient using coprocessing technique: A brief review. Curr. Drug Deliv. 2011; 8, 426–435.
42. Basf SE. Products & Industries: Ludipress®. https://industries.basf.com/en/Drug–Formulation/Ludipress.html (18. 8. 2016).
43. Avantor. Performance Profile: PanExcea® MH300G. https://www.avantormaterials.com. (18. 8. 2016).
44. F-Melt. Product Information. http://www.f-melt.com/product/ (9. 8. 2017).
45. Basf S. E. Products & Industries: Ludiflash®. https://industries.basf.com/en/Drug–Formulation/Ludiflash.html (18. 8. 2017).
46. Colorcon. Product brochure: Starcap 1500®. http://www.colorcon.com/products-formulation/all-products/excipients/capsules/starcap-1500 (14. 8. 2016).
47. Bala R., Khanna S., Pawar P. Polymers in fast disintegrating tablets – A review. Asian J. Pharm. Clin. Res. 2012; 8–14.
Štítky
Pharmacy Clinical pharmacologyČlánok vyšiel v časopise
Czech and Slovak Pharmacy
2018 Číslo 2
Najčítanejšie v tomto čísle
- On the content of the National part of the Czech Pharmacopoeia 2017
- Superdisintegrants used in pharmaceutical technology
- Microbiome in connection with metabolic syndrome and the therapeutic potential of its influencing
- Melatonin as a structural template in the development of novel drugs for neurodegenerative disorders